Nuclear medicine vendor Digirad yesterday updated its previous financial guidance for 2006 and provided initial guidance for 2007.
For 2006, the Poway, CA-based firm said it currently anticipates consolidated revenues at the high end of a previously announced range of $70.7 million to $71.5 million, and a consolidated loss at the low end of a previously announced range of $7.3 million to $7.8 million, including estimated stock-based compensation expense of $1.7 million.
For 2007, Digirad currently anticipates consolidated revenues in the range of $73 million to $76 million and a consolidated loss between $1.3 million and $3.3 million, including estimated stock-based compensation expense of $1.3 million.
By AuntMinnie.com staff writers
January 12, 2007
Related Reading
Digirad shows Q3 revenue slump, October 31, 2006
Digirad posts revenue gains, trims loss, August 3, 2006
Digirad touts new high-def detectors, June 7, 2006
Digirad Q1 revenues up, but loss grows, May 2, 2006
Digirad posts flat revenues, loss in 2005, February 17, 2006
Copyright © 2007 AuntMinnie.com
